Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
7 hedge funds and large institutions have $2.69M invested in Forward Pharma A/S American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
34% less capital invested
Capital invested by funds: $4.04M → $2.69M (-$1.36M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWM
Perigon Wealth Management
San Francisco,
California
|
+$68.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$8.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$73.1K |
| 2 |
Renaissance Technologies
New York
|
-$65K |
FWP Hedge Fund Activity: Q3 2022 in Review
7 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q3 2022, worth a combined $2.69M — down 34% from $4.04M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FWP positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Perigon Wealth Management, opening a new position worth an estimated $68.6K. The largest seller was Morgan Stanley, cutting an estimated $73.1K.
- 7 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q3 2022, up from 6 in Q2 2022.
- Funds reported $2.69M of Forward Pharma A/S American Depositary Shares stock for Q3 2022, down 34% quarter-over-quarter.
- 2 funds opened new Forward Pharma A/S American Depositary Shares positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q3 2022 was Perigon Wealth Management, an estimated $68.6K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q3 2022 was Morgan Stanley, an estimated $73.1K sold.
Based on aggregated 13F filings for Q3 2022.